Isoflurane and halothane attenuate endothelium-dependent vasodilation in rat coronary microvessels

Anesthesia and Analgesia

Volumn 84, Issue 2, 1997, Pages 278-284

  Park, Kyung W ^a   Dai, Hai B ^a   Lowenstein, Edward ^a   Darvish, Amir ^a   Sellke, Frank W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 8 BROMO CYCLIC GMP; ACETYLCHOLINE; CALCIMYCIN; CALCIUM ION; CYCLIC GMP; GUANYLATE CYCLASE; HALOTHANE; INDOMETACIN; ISOFLURANE; N(G) NITROARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANESTHESIA MECHANISM; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; CORONARY ARTERY DILATATION; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL; VASCULAR ENDOTHELIUM;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ACETYLCHOLINE; ANESTHETICS, INHALATION; ANIMALS; CALCIMYCIN; CALCIUM; CORONARY CIRCULATION; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; EPOPROSTENOL; HALOTHANE; INDOMETHACIN; IONOPHORES; ISOFLURANE; MICROCIRCULATION; MICROSCOPY, VIDEO; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; NITROPRUSSIDE; RATS; RATS, WISTAR; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS;

EID: 0031038609     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199702000-00008     Document Type: Article

References (29)

1. Muldoon SM, Hart JL, Bowen KA, Freas W. Attenuation of endothelium-mediated vasodilation by halothane. Anesthesiology 1988;68:31-7.
2. Toda H, Nakamura K, Hatano Y, et al. Halothane and isoflurane inhibit endothelium-dependent relaxation elicited by acetylcholine. Anesth Analg 1992;75:198-203.
3. Uggeri MJ, Proctor GJ, Johns RA. Halothane, enflurane, and isoflurane attenuate both receptor- and non-receptor-mediated EDRF production in rat thoracic aorta. Anesthesiology 1992;76:1012-7.
4. Hart JL, Jing M, Bina S, et al. Effects of halothane on EDRF/cGMP-mediated vascular smooth muscle relaxations. Anesthesiology 1993;79:323-31.
5. Jing M, Hart JL, Masaki E, et al. Vascular effects of halothane and isoflurane: cGMP dependent and independent actions. Life Sci 1995;56:19-29.
6. Biaise G, To Q. Isoflurane decreases EDRF/NO action but not its production [abstract]. Anesthesiology 1993;79:A670.
7. Park KW, Dai HB, Lowenstein E, Sellke FW. Vasomotor responses of rat coronary arteries to isoflurane and halothane depend on pre-exposure tone and vessel size. Anesthesiology 1995;82:1323-30.
8. Melkumyants AM, Balashov SA, Khayutin VM. Control of arterial lumen by shear stress on endothelium. News Physiol Sci 1995;10:204-10.
9. Komori K, Vanhoutte PM. Endothelium-derived hyperpolarizing factor. Blood Vessels 1990;27:238-45.
10. Bates JN, Baker MT, Guerra R, Jr, Harrison DG. Nitric oxide generation from nitroprusside by vascular tissue: evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem Pharmacol 1991;42:S157-65.
11. 2+-ATPaSe by cGMP-dependent protein kinase. Proc Natl Acad Sci USA 1987;84:5685-9.
12. Lincoln TM. Cyclic GMP and mechanisms of vasodilation. Pharmacol Ther 1989;41:479-502.
13. Park KW, Dai HB, Lowenstein E, et al. Heterogeneous vasomotor effect of isoflurane on rabbit coronary microvessels. Anesthesiology 1994;81:1190-7.
14. Park KW, Dai HB, Lowenstein E, et al. Isoflurane attenuates cAMP-mediated vasodilation in rat microvessels. Circulation 1995;92:II423-7.
15. Johns RA, Tichotsky A, Muro M, et al. Halothane and isoflurane inhibit endothelium-derived relaxing factor-dependent cyclic guanosine monophosphate accumulation in endothelial cell-vascular smooth muscle co-cultures independent of an effect on guanylyl cyclase action. Anesthesiology 1995;83:823-34.
16. Zuo Z, Tichotsky A, Johns RA. Halothane and isoflurane inhibit vasodilation due to constitutive but not inducible nitric oxide synthase. Anesthesiology 1996;84:1156-65.
17. Jing M, Bina S, Verma A, et al. Effects of halothane and isoflurane on carbon monoxide-induced relaxations in the rat aorta. Anesthesiology 1996;85:347-54.
18. 2α. Blood Vessels 1989;26:235-45.
19. Nakamura Y, Parent R, Lavallee M. Opposite effects of substance P on conductance and resistance coronary vessels in conscious dogs. Am J Physiol 1990;258:H565-73.
20. Feelisch M, te Poel M, Zamora R, et al. Understanding the controversy over the identity of EDRF. Nature 1994;368:62-5.
21. Yoshida K, Okabe E. Selective impairment of endothelium-dependent relaxation by sevoflurane: oxygen free radicals participation. Anesthesiology 1992;76:440-7.
22. Park KW, Dai HB, Lowenstein E, et al. Oxygen-derived free radicals mediate isoflurane-induced vasoconstriction of rabbit coronary resistance arteries. Anesth Analg 1995;80:1163-7.
23. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986;250:H822-7.
24. Severina IS. Activation of guanylate cyclase and the regulatory role of cyclic 3′,5′-guanosine monophosphate. Biochem Int 1988; 17:265-78.
25. Ignarro LJ, Wood KS, Wolin MS. Regulation of purified soluble guanylate cyclase by porphyrins and metalloporphyrins: a unifying concept. Adv Cycl Nucl Res 1984;17:267-74.
26. Ignarro LJ, Wood KS, Wolin MS. Activation of purified soluble guanylate cyclase by protoporphyrin IX. Proc Natl Acad Sci USA 1982;79:2870-3.
27. Schmidt HHHW. NO., CO, .OH. Endogenous soluble guanylyl cyclase-activating factors. FEBS Lett 1992;307:102-7.
28. Graff G, Stephenson JH, Glass DB, et al. Activation of soluble splenic cell guanylate cyclase by prostaglandin endoperoxides and fatty acid hydroperoxides. J Biol Chem 1978;253: 7662-76.
29. Jones CJH, Kuo L, Davis MJ, Chilian WM. Distribution and control of coronary microvascular resistance. Adv Exp Med Biol 1993;346:181-8.